Immune Thrombocytopenia: A Rare Haematological Manifestation of Sarcoidosis

Authors

DOI:

https://doi.org/10.24950/rspmi.545

Keywords:

Purpura, Thrombocytopenic, Idiopathic/etiology, Thrombocytopenia/etiology, Sarcoidosis/complications

Abstract

Sarcoidosis is a multisystemic granulomatous disorder of unknown aetiology. Although the lungs are the primary site of involvement, the disease can affect virtually any organ, leading to a wide variety of clinical manifestations. Haematological abnormalities are uncommon, and most frequently include lymphopenia and anaemia. Thrombocytopenia, however, is rare, and three distinct pathophysiological mechanisms have been described: immune platelet destruction, splenomegaly with hypersplenism, and bone marrow infiltration. We report a case of sarcoidosis presenting with pulmonary and cutaneous involvement, and severe acute thrombocytopenia. Bone marrow aspirate was consistent with an immune process, assumed as the primary cause for the cytopenia, but bone marrow biopsy also showed multiple noncaseating granulomas, and a CT scan revealed massive splenomegaly. There are no guidelines for the management of thrombocytopenia in sarcoidosis. In our patient, treatment with intravenous immune globulin and corticosteroids restored normal platelet count.

Downloads

Download data is not yet available.

References

Jersild M. The syndrome of Heerfordt (uveo-parotid fever), a manifestation of Boeck's sarcoid. Acta Med Scand. 1938;97:322-8

Mahévas M, Le Page L, Salle V, Lescure FX, Smail A, Cevallos R, et al. Thrombocytopenia in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2006;13:229-35.

Mahévas M, Chiche L, Uzunhan Y, Khellaf M, Morin AS, Le Guenno G, et al. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients. Medicine. 2011;90:269-78. doi: 10.1097/MD.0b013e31822618b3.

Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and the ERS Executive Comittee, February 1999. Am J Respir Crit Care Med. 1999;160:736.

Mayock RL, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis. Analysis of 145 patients, with a review of nine series selected from the literature. Am J Med. 1963;35:67-89. doi: 10.1016/0002-9343(63)90165-7.

Mañá J, Rubio-Rivas M, Villalba N, Marcoval J, Iriarte A, Molina-Molina M, et al. Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: Cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain. Medicine. 2017;96:e7595. doi: 10.1097/MD.0000000000007595.

Moulis G, Palmaro A, Montastruc JL, Godeau B, Lapeyre-Mestre M, Sailler L. Epidemiology of incident immune thrombocytopenia: a nationwide population-based study in France. Blood. 2014;124:3308-15. doi: 10.1182/ blood-2014-05-578336.

Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164:1885-9. doi: 10.1164/ ajrccm.164.10.2104046.

Carrillo-Pérez DL, Apodaca-Cháveza EI, Carrillo-Maravilla E, Mejía-Ávila M, Hernández-Oropeza JL, Reyes E, et al. Sarcoidosis: a single hospital-based study in a 24-year period. Rev Invest Clin. 2015;67:33-8.

Matsuda N, Iida S, Ogino Y, Saito N, Yasutake M. Bone Marrow Sarcoidosis with Pancytopenia and Renal Failure Presenting as Fever of Unknown Origin: The Pivotal Role of 18F-FDG in Lesion Detection. J Nippon Med Sch. 2021;88:145-8. doi: 10.1272/jnms.JNMS.2021_88-307.

Purohit A, Aggarwal M, Singh PK, Mahapatra M, Seth T, Tyagi S, et al. Re-evaluation of Need for Bone Marrow Examination in Patients with Isolated Thrombocytopenia Contributors. Indian J Hematol Blood Transfus. 2016;32:193-6. doi: 10.1007/s12288-015-0533-2.

Ihtesham A, Maqbool S, Nadeem M, Bilawal Abbas Janjua M, Sundus O, Bakht Naqqash A, et al. Helicobacter pylori induced Immune Thrombocytopenic Purpura and perspective role of Helicobacter pylori eradication therapy for treating Immune Thrombocytopenic Purpura. AIMS Microbiol. 2021;7:284-303. doi: 10.3934/microbiol.2021018.

Hill LJ, Tung EE. From prednisone to pylori: a case of Helicobacter pylori-induced chronic immune thrombocytopenia. BMJ Case Rep. 2014;2014:bcr2014205786. doi: 10.1136/bcr-2014-205786.

Gerke AK. Treatment of Sarcoidosis: A Multidisciplinary Approach. Front Immunol. 2020;11:545413. doi: 10.3389/fimmu.2020.545413.

Published

2022-12-19

How to Cite

1.
Monteiro M, Pimentel J, Rodrigues M, Costa A, Jesus M. Immune Thrombocytopenia: A Rare Haematological Manifestation of Sarcoidosis. RPMI [Internet]. 2022 Dec. 19 [cited 2024 Nov. 23];29(4):278-82. Available from: https://revista.spmi.pt/index.php/rpmi/article/view/545

Most read articles by the same author(s)